Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 20, 2025
Headlands Research announced the opening of Headlands Research Twin Cities (HRTC), its 23rd fully owned site. Strategically situated in the Minneapolis–St. Paul metro area, the new center offers pharmaceutical sponsors and CROs rapid, single-contract...
read more
Made Scientific recently held a ribbon-cutting ceremony to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey.
read more
Upperton Pharma Solutions has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored ...
read more
IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Under the terms of the long-term agreement, customers can use software, data, technology, and service offerings ...
read more
Avixgen, a subsidiary of Dx&Vx, has signed a licensing-out agreement worth approximately $360M with a U.S. biotechnology company for its next-generation drug delivery platform, ACP (Advanced Cell Penetrating Peptide). Avixgen is a drug development ...
read more
Thursday, August 14, 2025
Avista Therapeutics and Forge Biologics announced a strategic partnership to advance the development and manufacturing of AVST-101, Avista’s lead gene therapy candidate targeting X-linked retinoschisis (XLRS), a serious inherited retinal disease.
read more
Thursday, August 14, 2025
THL Partners, a private equity firm investing in middle market growth companies, announced the entry into a definitive agreement to acquire Headlands Research, a multinational network of clinical trial sites, from funds managed by global investment ...
read more
Wednesday, August 13, 2025
Veranova announced that a routine current Good Manufacturing Practice (cGMP) surveillance inspection of Veranova’s Devens, Massachusetts site, completed by the FDA New England District on July 31, 2025, concluded without any Form 483s and with a “No ...
read more
Wednesday, August 13, 2025
Woodstock Sterile Solutions and Halo Pharma have named John Bender as the new Vice President of Business Development for the two organizations.
read more
Hongene has appointed Dr. Pieter Cullis, a renowned innovator in lipid nanoparticle (LNP) drug delivery, to its scientific advisory board. This strategic addition reinforces Hongene’s commitment to advancing RNA therapeutics.
read more
SIRIO Pharma has reported record revenues in the APAC (excluding China) region, with construction set to begin on a major new manufacturing facility in Thailand in Q4 2025. Growth has been driven by rising demand across Southeast Asia, with key ...
read more
Pinnaql has acquired Validation & Engineering Group, Inc. (VEG), a provider of commissioning, qualification, and validation (CQV) services to the pharmaceutical and life sciences industries.
read more
Bionova Scientific, a subsidiary of Asahi Kasei, announced the opening of a 10,000 square-foot plasmid DNA (pDNA) development and production facility in The Woodlands, Texas.
read more
Bora Pharmaceuticals announced plans for significant investments to expand its manufacturing and packaging capabilities at its facility in Maple Grove, Minnesota. This is a major upgrade to the site, which Bora acquired in 2024 as part of its $210 ...
read more
Thursday, August 07, 2025
Aragen announced the appointment of Aniel Khubchandani as CEO of its Development & Manufacturing Solutions business. Aniel will be a member of Aragen’s Management Council and will be based in Hyderabad.
read more